查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1617700

醫療保健契約製造市場：按製造類型、最終用戶分類 - 2025-2030 年全球預測

Healthcare Contract Manufacturing Market by Manufacturing Type (Accessories Manufacturing, Assembly Manufacturing, Component Manufacturing), End-Users (Medical Device Companies, Pharmaceutical & Biopharmaceutical Companies) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年，醫療保健契約製造市場價值為1860億美元，預計到2024年將達到2016.8億美元，複合年成長率為8.49%，到2030年將達到3292.2億美元。

醫療保健契約製造是指將生產過程外包給專業的第三方公司，讓製藥和醫療設備公司專注於研發等核心能力。這項需求是由成本效率、擴充性、法規遵循和專業知識的獲取所驅動的。應用領域廣泛，包括製藥、生技產品、醫療設備及診斷。最終用途包括醫院、實驗室、商業企業等。市場成長是由不斷增加的研發投資、對學名藥和生技藥品的強勁需求以及醫療技術的進步所推動的。人口迅速老化和慢性病盛行率上升進一步增加了這項需求。由於醫療保健計劃的擴大和醫療支出的增加，新興市場提供了巨大的商機。公司可以受益於利用當地製造業的優勢並與區域企業建立策略夥伴關係。然而，他們面臨嚴格的法規環境、複雜的物流、品質保證挑戰和智慧財產權問題等挑戰。為了應對這些挑戰，公司必須投資強大的品管流程並確保符合國際標準。創新路徑包括採用 3D 列印和物聯網等先進製造技術、利用區塊鏈簡化供應鏈以及利用資料分析來獲得預測見解。環保生產技術等永續實踐也有望在競爭格局中脫穎而出。市場既競爭又協作，要求製造商保持靈活性，以適應不斷變化的客戶需求和監管變化。市場的動態本質要求不斷創新，不僅在產品供應方面，而且在服務供應方面，確保對市場波動的快速反應。對新興市場和技術進步的策略關注可以幫助企業實現永續成長。最終，了解當地消費行為和監管細微差別對於抓住醫療保健契約製造領域的全球商機至關重要。

主要市場統計
基準年[2023] 1860億美元
預計年份 [2024] 2016.8億美元
預測年份 [2030] 3292.2億美元
複合年成長率（%） 8.49%

市場動態：揭示快速發展的醫療保健契約製造市場的關鍵市場洞察

醫療保健契約製造市場正在因供需的動態相互作用而發生轉變。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 製藥公司外包端到端服務的趨勢不斷成長
    • 契約製造增加對先進製造技術的投資
    • 對一站式開發和製造合約組織的需求不斷增加
  • 市場限制因素
    • 外包中的合規問題以及嚴格的法規和法律體制
  • 市場機會
    • 對核子醫學和專科藥物的日益關注
    • 對生物療法的需求不斷成長
  • 市場挑戰
    • 影響醫療保健契約製造組織盈利的運轉率問題

波特五力：駕馭醫療保健契約製造市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解醫療保健契約製造市場的外部影響

外部宏觀環境因素在塑造醫療保健契約製造市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解醫療保健契約製造市場的競爭狀況

對醫療保健契約製造市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣供應商在醫療保健契約製造市場的績效評估

FPNV定位矩陣是評估醫療保健契約製造市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議，規劃醫療保健契約製造市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，醫療保健契約製造市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 製藥公司端到端外包趨勢增加
      • 契約製造製造商增加對先進製造技術的投資
      • 對一站式合約開發和製造組織的需求不斷增加
    • 抑制因素
      • 外包中的合規問題以及嚴格的法規和法律體制
    • 機會
      • 對核子醫學和專科藥物的關注增加
      • 生物治療的需求不斷增加
    • 任務
      • 影響醫療保健契約製造組織盈利的產能利用率問題
  • 市場區隔分析
    • 製造類型：製造流程的進步透過契約製造為不同的客戶需求提供客製化的解決方案。
    • 最終用戶：契約製造開始開發高度複雜的生物產品。
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章按製造類型分類的醫療保健契約製造市場

  • 配件製造
  • 組裝製造
  • 零件製造
  • 裝置製造
  • 藥品製造
    • 先進的藥物傳輸配方
    • 原料藥/原料藥
    • 最終劑量配方
    • 包裹

第7章 醫療保健契約製造市場：依最終用戶分類

  • 醫療設備公司
  • 製藥和生物製藥公司

第8章美洲醫療保健契約製造市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太地區醫療保健契約製造市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章 歐洲、中東和非洲的醫療保健契約製造市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Biomeric 宣布與 Precision Concepts Medical 合併
    • PCI Pharma 宣布斥資 5,000 萬美元擴建伊利諾州注射藥品廠
    • Medisurge 與 Signal Medical 宣布策略聯盟
  • 戰略分析和建議

公司名單

  • AbbVie, Inc.
  • Aenova Group
  • Almac Group
  • Baxter International, Inc.
  • Biozoc Inc.
  • Boehringer Ingelheim International GmbH
  • Cambrex Corporation
  • Curia Global, Inc.
  • Evonik Industries AG
  • Famar Group
  • Jubilant Biosys Limited
  • Lonza Group Ltd.
  • Mitsubishi Tanabe Pharma Corporation
  • Pfizer Inc.
  • Pidolma Healthcare Private Limited
  • Recipharm AB
  • Thermo Fisher Scientific Inc.
Product Code: MRR-8C74ADFC054D

The Healthcare Contract Manufacturing Market was valued at USD 186.00 billion in 2023, expected to reach USD 201.68 billion in 2024, and is projected to grow at a CAGR of 8.49%, to USD 329.22 billion by 2030.

Healthcare contract manufacturing involves outsourcing production processes to specialized third-party firms, enabling pharmaceutical and medical device companies to focus on core competencies like research and development. The necessity stems from cost efficiency, scalability, regulatory compliance, and access to specialized expertise. Application areas span pharmaceuticals, biotechnology products, medical devices, and diagnostics. End-use scopes include hospitals, research labs, and commercial enterprises. Market growth is propelled by increased R&D investments, robust demand for generics and biologics, and advancements in medical technology. The burgeoning aging population and rising prevalence of chronic diseases further amplify this demand. Developing markets offer ripe opportunities due to expansive healthcare initiatives and increasing healthcare spending. Companies can capitalize by leveraging local manufacturing benefits and forming strategic partnerships with regional firms. Nonetheless, the market faces hurdles such as stringent regulatory environments, complex logistics, quality assurance challenges, and intellectual property issues. To navigate these, firms must invest in robust quality control processes and ensure compliance with international standards. Innovation avenues entail embracing advanced manufacturing technologies like 3D printing and IoT, streamlining supply chains through blockchain, and utilizing data analytics for predictive insights. Sustainable practices, such as eco-friendly production techniques, are also promising for differentiation in a competitive landscape. The market is highly competitive yet collaborative, requiring manufacturers to maintain flexibility to adapt to evolving client demands and regulatory shifts. The market's dynamic nature calls for continuous innovation, not just in product offerings but also in service delivery, ensuring rapid response to market fluctuations. With a strategic focus on emerging markets and technological advancements, companies can achieve sustainable growth. Ultimately, understanding local consumer behavior and regulatory nuances will be crucial for seizing global opportunities in healthcare contract manufacturing.

KEY MARKET STATISTICS
Base Year [2023] USD 186.00 billion
Estimated Year [2024] USD 201.68 billion
Forecast Year [2030] USD 329.22 billion
CAGR (%) 8.49%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Healthcare Contract Manufacturing Market

The Healthcare Contract Manufacturing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing trend of outsourcing end-to-end services by pharmaceutical companies
    • Rising investments in advanced manufacturing technologies by contract manufacturers
    • Increasing demand for one-stop-shop contract development & manufacturing organization
  • Market Restraints
    • Compliance issues in outsourcing coupled with stringent regulatory and legal frameworks
  • Market Opportunities
    • Growing focus on nuclear medicine and specialty drugs
    • Increasing need for biological therapies
  • Market Challenges
    • Capacity utilization issues affecting the profitability of healthcare contract manufacturing organization

Porter's Five Forces: A Strategic Tool for Navigating the Healthcare Contract Manufacturing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Healthcare Contract Manufacturing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Healthcare Contract Manufacturing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Healthcare Contract Manufacturing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Healthcare Contract Manufacturing Market

A detailed market share analysis in the Healthcare Contract Manufacturing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Healthcare Contract Manufacturing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Healthcare Contract Manufacturing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Healthcare Contract Manufacturing Market

A strategic analysis of the Healthcare Contract Manufacturing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Healthcare Contract Manufacturing Market, highlighting leading vendors and their innovative profiles. These include AbbVie, Inc., Aenova Group, Almac Group, Baxter International, Inc., Biozoc Inc., Boehringer Ingelheim International GmbH, Cambrex Corporation, Curia Global, Inc., Evonik Industries AG, Famar Group, Jubilant Biosys Limited, Lonza Group Ltd., Mitsubishi Tanabe Pharma Corporation, Pfizer Inc., Pidolma Healthcare Private Limited, Recipharm AB, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Healthcare Contract Manufacturing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Manufacturing Type, market is studied across Accessories Manufacturing, Assembly Manufacturing, Component Manufacturing, Device Manufacturing, and Pharmaceutical Manufacturing. The Pharmaceutical Manufacturing is further studied across Advanced Drug Delivery Formulations, API/Bulk Drugs, Finished Dose Formulations, and Packaging.
  • Based on End-Users, market is studied across Medical Device Companies and Pharmaceutical & Biopharmaceutical Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing trend of outsourcing end-to-end services by pharmaceutical companies
      • 5.1.1.2. Rising investments in advanced manufacturing technologies by contract manufacturers
      • 5.1.1.3. Increasing demand for one-stop-shop contract development & manufacturing organization
    • 5.1.2. Restraints
      • 5.1.2.1. Compliance issues in outsourcing coupled with stringent regulatory and legal frameworks
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing focus on nuclear medicine and specialty drugs
      • 5.1.3.2. Increasing need for biological therapies
    • 5.1.4. Challenges
      • 5.1.4.1. Capacity utilization issues affecting the profitability of healthcare contract manufacturing organization
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Manufacturing Type: Advancements in the manufacturing processes offer customized solutions for diverse client requirements through contract manufacturing
    • 5.2.2. End-User: Contract manufacturers expanded penetration to develop highly complex biological products
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Healthcare Contract Manufacturing Market, by Manufacturing Type

  • 6.1. Introduction
  • 6.2. Accessories Manufacturing
  • 6.3. Assembly Manufacturing
  • 6.4. Component Manufacturing
  • 6.5. Device Manufacturing
  • 6.6. Pharmaceutical Manufacturing
    • 6.6.1. Advanced Drug Delivery Formulations
    • 6.6.2. API/Bulk Drugs
    • 6.6.3. Finished Dose Formulations
    • 6.6.4. Packaging

7. Healthcare Contract Manufacturing Market, by End-Users

  • 7.1. Introduction
  • 7.2. Medical Device Companies
  • 7.3. Pharmaceutical & Biopharmaceutical Companies

8. Americas Healthcare Contract Manufacturing Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Healthcare Contract Manufacturing Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Healthcare Contract Manufacturing Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
    • 11.3.1. Biomerics Announces Merger with Precision Concepts Medical
    • 11.3.2. PCI Pharma Unveils Plans for USD 50 Millions Expansion At Illinois Injectables Site
    • 11.3.3. Medisurge and Signal Medical Announce Strategic Partnership
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AbbVie, Inc.
  • 2. Aenova Group
  • 3. Almac Group
  • 4. Baxter International, Inc.
  • 5. Biozoc Inc.
  • 6. Boehringer Ingelheim International GmbH
  • 7. Cambrex Corporation
  • 8. Curia Global, Inc.
  • 9. Evonik Industries AG
  • 10. Famar Group
  • 11. Jubilant Biosys Limited
  • 12. Lonza Group Ltd.
  • 13. Mitsubishi Tanabe Pharma Corporation
  • 14. Pfizer Inc.
  • 15. Pidolma Healthcare Private Limited
  • 16. Recipharm AB
  • 17. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. HEALTHCARE CONTRACT MANUFACTURING MARKET RESEARCH PROCESS
  • FIGURE 2. HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. HEALTHCARE CONTRACT MANUFACTURING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. HEALTHCARE CONTRACT MANUFACTURING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. HEALTHCARE CONTRACT MANUFACTURING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. HEALTHCARE CONTRACT MANUFACTURING MARKET DYNAMICS
  • TABLE 7. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY ACCESSORIES MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY ASSEMBLY MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COMPONENT MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY DEVICE MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY ADVANCED DRUG DELIVERY FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY API/BULK DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY FINISHED DOSE FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PACKAGING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MEDICAL DEVICE COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. MEXICO HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. AUSTRALIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 47. AUSTRALIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. CHINA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 50. CHINA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. INDIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 53. INDIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. INDONESIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 56. INDONESIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. JAPAN HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 59. JAPAN HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. MALAYSIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 62. MALAYSIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. PHILIPPINES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 65. PHILIPPINES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. SINGAPORE HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 68. SINGAPORE HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. SOUTH KOREA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 71. SOUTH KOREA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. TAIWAN HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 74. TAIWAN HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. THAILAND HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 77. THAILAND HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. VIETNAM HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 80. VIETNAM HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. DENMARK HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 87. DENMARK HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. EGYPT HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 90. EGYPT HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. FINLAND HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 93. FINLAND HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. FRANCE HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 96. FRANCE HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. GERMANY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 99. GERMANY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. ISRAEL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 102. ISRAEL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. ITALY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 105. ITALY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. NETHERLANDS HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 108. NETHERLANDS HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. NIGERIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 111. NIGERIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. NORWAY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 114. NORWAY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. POLAND HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 117. POLAND HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. QATAR HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 120. QATAR HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. RUSSIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 123. RUSSIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. SAUDI ARABIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 126. SAUDI ARABIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH AFRICA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH AFRICA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. SPAIN HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 132. SPAIN HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. SWEDEN HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 135. SWEDEN HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. SWITZERLAND HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 138. SWITZERLAND HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. TURKEY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 141. TURKEY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED ARAB EMIRATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED ARAB EMIRATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED KINGDOM HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED KINGDOM HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 148. HEALTHCARE CONTRACT MANUFACTURING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 149. HEALTHCARE CONTRACT MANUFACTURING MARKET, FPNV POSITIONING MATRIX, 2023